[14] Another study describing genomic analysis of 675 cases of NSCLC showed only one case of FGFR3-TACC3 fusion (breakpoint not specified), this was associated with existing CDKN2A-loss and MDM2 amplification. The gene discussed is FGFR3; the disease is non-small cell lung carcinoma.